CRMD, RANI, CELC, RAPT: four biotech stocks flying high today and why

Core Insights - Biotech stocks are experiencing significant gains, with several clinical-stage companies reporting double-digit increases due to new catalysts [1] Group 1: Earnings and Financial Performance - Companies are reporting earnings beats, contributing to the positive momentum in biotech stocks [1] - Promising trial data has been a key driver for the stock price increases among clinical-stage firms [1] Group 2: Partnerships and Collaborations - Billion-dollar partnerships are being formed, further enhancing the market outlook for these biotech companies [1]